Carmen A T Reep, Lucas M Fleuren, Leo Heunks, Evert-Jan Wils
{"title":"COVID-19和重症监护病房中脉搏氧饱和度的种族差异。","authors":"Carmen A T Reep, Lucas M Fleuren, Leo Heunks, Evert-Jan Wils","doi":"10.1097/CCE.0000000000001132","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives background: </strong>This study aimed to assess the impact of race on pulse oximetry reliability, taking into account Spo<sub>2</sub> ranges, COVID-19 diagnosis, and ICU admission.</p><p><strong>Design: </strong>Retrospective cohort study covering admissions from January 2020 to April 2024.</p><p><strong>Setting: </strong>National COVID Cohort Collaborative (N3C) database, consisting of electronic health records from 80 U.S. institutions.</p><p><strong>Patients/subjects: </strong>Patients were selected from the N3C database based on the availability of data on self-identified race and both pulse oximetry estimated Spo<sub>2</sub> and Sao<sub>2</sub>. Subgroups included patients in ICU and non-ICU settings, with or without a diagnosis of COVID-19 disease.</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>The agreement between Spo<sub>2</sub> and Sao<sub>2</sub> was assessed across racial groups (American Indian or Alaska Native, Asian, Black, Hispanic or Latino, Pacific Islander, and White). Each patient's initial Sao<sub>2</sub> measurement was matched with the closest Spo<sub>2</sub> values recorded within the preceding 10-minute time frame. The risk of hidden hypoxemia (Spo<sub>2</sub> ≥ 88% but Sao<sub>2</sub> < 88%) was determined for various Spo<sub>2</sub> ranges, races, and clinical scenarios. We used a generalized logistic mixed-effects model to evaluate the impact of relevant variables, such as COVID-19, ICU admission, age, sex, race, and Spo<sub>2</sub>, on the risk of hidden hypoxemia, while accounting for the random effects within each hospital. A total of 80,541 patients were included, consisting of 596 American Indian or Alaska Native, 2,729 Asian, 11,889 Black, 13,154 Hispanic or Latino, 221 Pacific Islander, and 51,952 White individuals. Discrepancies between Spo<sub>2</sub> and Sao<sub>2</sub> were observed across all racial groups, with the most pronounced bias in Black patients. Hidden hypoxemia rates were higher in Black patients across all Spo<sub>2</sub> subgroups, for all clinical scenarios. The odds of hidden hypoxemia were higher for Black and Hispanic or Latino patients and for those with COVID-19 disease.</p><p><strong>Conclusions: </strong>Race significantly impacts pulse oximetry reliability. Not only Black and Hispanic or Latino patients were at higher risk for hidden hypoxemia, but also those admitted with a COVID-19 diagnosis. Future in-depth explorations into the underlying causes and potential solutions are needed.</p>","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":"6 8","pages":"e1132"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11338246/pdf/","citationCount":"0","resultStr":"{\"title\":\"Racial Disparities in Pulse Oximetry, in COVID-19 and ICU Settings.\",\"authors\":\"Carmen A T Reep, Lucas M Fleuren, Leo Heunks, Evert-Jan Wils\",\"doi\":\"10.1097/CCE.0000000000001132\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives background: </strong>This study aimed to assess the impact of race on pulse oximetry reliability, taking into account Spo<sub>2</sub> ranges, COVID-19 diagnosis, and ICU admission.</p><p><strong>Design: </strong>Retrospective cohort study covering admissions from January 2020 to April 2024.</p><p><strong>Setting: </strong>National COVID Cohort Collaborative (N3C) database, consisting of electronic health records from 80 U.S. institutions.</p><p><strong>Patients/subjects: </strong>Patients were selected from the N3C database based on the availability of data on self-identified race and both pulse oximetry estimated Spo<sub>2</sub> and Sao<sub>2</sub>. Subgroups included patients in ICU and non-ICU settings, with or without a diagnosis of COVID-19 disease.</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>The agreement between Spo<sub>2</sub> and Sao<sub>2</sub> was assessed across racial groups (American Indian or Alaska Native, Asian, Black, Hispanic or Latino, Pacific Islander, and White). Each patient's initial Sao<sub>2</sub> measurement was matched with the closest Spo<sub>2</sub> values recorded within the preceding 10-minute time frame. The risk of hidden hypoxemia (Spo<sub>2</sub> ≥ 88% but Sao<sub>2</sub> < 88%) was determined for various Spo<sub>2</sub> ranges, races, and clinical scenarios. We used a generalized logistic mixed-effects model to evaluate the impact of relevant variables, such as COVID-19, ICU admission, age, sex, race, and Spo<sub>2</sub>, on the risk of hidden hypoxemia, while accounting for the random effects within each hospital. A total of 80,541 patients were included, consisting of 596 American Indian or Alaska Native, 2,729 Asian, 11,889 Black, 13,154 Hispanic or Latino, 221 Pacific Islander, and 51,952 White individuals. Discrepancies between Spo<sub>2</sub> and Sao<sub>2</sub> were observed across all racial groups, with the most pronounced bias in Black patients. Hidden hypoxemia rates were higher in Black patients across all Spo<sub>2</sub> subgroups, for all clinical scenarios. The odds of hidden hypoxemia were higher for Black and Hispanic or Latino patients and for those with COVID-19 disease.</p><p><strong>Conclusions: </strong>Race significantly impacts pulse oximetry reliability. Not only Black and Hispanic or Latino patients were at higher risk for hidden hypoxemia, but also those admitted with a COVID-19 diagnosis. Future in-depth explorations into the underlying causes and potential solutions are needed.</p>\",\"PeriodicalId\":93957,\"journal\":{\"name\":\"Critical care explorations\",\"volume\":\"6 8\",\"pages\":\"e1132\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11338246/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical care explorations\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/CCE.0000000000001132\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/8/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical care explorations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/CCE.0000000000001132","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Racial Disparities in Pulse Oximetry, in COVID-19 and ICU Settings.
Objectives background: This study aimed to assess the impact of race on pulse oximetry reliability, taking into account Spo2 ranges, COVID-19 diagnosis, and ICU admission.
Design: Retrospective cohort study covering admissions from January 2020 to April 2024.
Setting: National COVID Cohort Collaborative (N3C) database, consisting of electronic health records from 80 U.S. institutions.
Patients/subjects: Patients were selected from the N3C database based on the availability of data on self-identified race and both pulse oximetry estimated Spo2 and Sao2. Subgroups included patients in ICU and non-ICU settings, with or without a diagnosis of COVID-19 disease.
Interventions: None.
Measurements and main results: The agreement between Spo2 and Sao2 was assessed across racial groups (American Indian or Alaska Native, Asian, Black, Hispanic or Latino, Pacific Islander, and White). Each patient's initial Sao2 measurement was matched with the closest Spo2 values recorded within the preceding 10-minute time frame. The risk of hidden hypoxemia (Spo2 ≥ 88% but Sao2 < 88%) was determined for various Spo2 ranges, races, and clinical scenarios. We used a generalized logistic mixed-effects model to evaluate the impact of relevant variables, such as COVID-19, ICU admission, age, sex, race, and Spo2, on the risk of hidden hypoxemia, while accounting for the random effects within each hospital. A total of 80,541 patients were included, consisting of 596 American Indian or Alaska Native, 2,729 Asian, 11,889 Black, 13,154 Hispanic or Latino, 221 Pacific Islander, and 51,952 White individuals. Discrepancies between Spo2 and Sao2 were observed across all racial groups, with the most pronounced bias in Black patients. Hidden hypoxemia rates were higher in Black patients across all Spo2 subgroups, for all clinical scenarios. The odds of hidden hypoxemia were higher for Black and Hispanic or Latino patients and for those with COVID-19 disease.
Conclusions: Race significantly impacts pulse oximetry reliability. Not only Black and Hispanic or Latino patients were at higher risk for hidden hypoxemia, but also those admitted with a COVID-19 diagnosis. Future in-depth explorations into the underlying causes and potential solutions are needed.